Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Double-Blind, Parallel Group, Placebo Controlled Study of Creatine in Subjects With Treated Parkinson's Disease (PD) Long Term Study (LS-1)

NCT00449865 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.

NCT NCT00449865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00449865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Double-Blind, Parallel Group, Placebo Controlled Study of Creatine in Subjects With Treated Parkinson's Disease (PD) Long Term Study (LS-1)
Lead sponsor
University of Rochester
Phase
Phase 3
Overall status
Terminated
Start date
March 31, 2007
Completion date
May 31, 2014
Enrollment
1,741 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease